S&P 500   3,117.43 (+0.15%)
DOW   27,677.79 (+0.10%)
QQQ   202.43 (+0.51%)
AAPL   265.58 (+1.47%)
FB   199.36 (+0.33%)
MSFT   149.93 (+0.05%)
GOOGL   1,326.96 (+0.61%)
AMZN   1,740.48 (-1.15%)
CGC   18.60 (+1.20%)
NVDA   208.74 (-0.32%)
MU   46.62 (+0.69%)
BABA   200.00 (+3.23%)
GE   10.79 (-1.01%)
TSLA   330.37 (-0.80%)
T   38.19 (+0.24%)
AMD   39.62 (-0.18%)
ACB   2.44 (-1.61%)
F   8.93 (-0.22%)
PRI   134.30 (+0.83%)
NFLX   302.86 (-0.48%)
BAC   33.09 (-0.18%)
GILD   65.93 (-1.23%)
DIS   147.44 (-0.57%)
S&P 500   3,117.43 (+0.15%)
DOW   27,677.79 (+0.10%)
QQQ   202.43 (+0.51%)
AAPL   265.58 (+1.47%)
FB   199.36 (+0.33%)
MSFT   149.93 (+0.05%)
GOOGL   1,326.96 (+0.61%)
AMZN   1,740.48 (-1.15%)
CGC   18.60 (+1.20%)
NVDA   208.74 (-0.32%)
MU   46.62 (+0.69%)
BABA   200.00 (+3.23%)
GE   10.79 (-1.01%)
TSLA   330.37 (-0.80%)
T   38.19 (+0.24%)
AMD   39.62 (-0.18%)
ACB   2.44 (-1.61%)
F   8.93 (-0.22%)
PRI   134.30 (+0.83%)
NFLX   302.86 (-0.48%)
BAC   33.09 (-0.18%)
GILD   65.93 (-1.23%)
DIS   147.44 (-0.57%)
S&P 500   3,117.43 (+0.15%)
DOW   27,677.79 (+0.10%)
QQQ   202.43 (+0.51%)
AAPL   265.58 (+1.47%)
FB   199.36 (+0.33%)
MSFT   149.93 (+0.05%)
GOOGL   1,326.96 (+0.61%)
AMZN   1,740.48 (-1.15%)
CGC   18.60 (+1.20%)
NVDA   208.74 (-0.32%)
MU   46.62 (+0.69%)
BABA   200.00 (+3.23%)
GE   10.79 (-1.01%)
TSLA   330.37 (-0.80%)
T   38.19 (+0.24%)
AMD   39.62 (-0.18%)
ACB   2.44 (-1.61%)
F   8.93 (-0.22%)
PRI   134.30 (+0.83%)
NFLX   302.86 (-0.48%)
BAC   33.09 (-0.18%)
GILD   65.93 (-1.23%)
DIS   147.44 (-0.57%)
S&P 500   3,117.43 (+0.15%)
DOW   27,677.79 (+0.10%)
QQQ   202.43 (+0.51%)
AAPL   265.58 (+1.47%)
FB   199.36 (+0.33%)
MSFT   149.93 (+0.05%)
GOOGL   1,326.96 (+0.61%)
AMZN   1,740.48 (-1.15%)
CGC   18.60 (+1.20%)
NVDA   208.74 (-0.32%)
MU   46.62 (+0.69%)
BABA   200.00 (+3.23%)
GE   10.79 (-1.01%)
TSLA   330.37 (-0.80%)
T   38.19 (+0.24%)
AMD   39.62 (-0.18%)
ACB   2.44 (-1.61%)
F   8.93 (-0.22%)
PRI   134.30 (+0.83%)
NFLX   302.86 (-0.48%)
BAC   33.09 (-0.18%)
GILD   65.93 (-1.23%)
DIS   147.44 (-0.57%)
Log in

NYSE:JNJ - Johnson & Johnson Stock Price, Forecast & News

$139.56
+0.18 (+0.13 %)
(As of 12/5/2019 04:00 PM ET)
Today's Range
$137.95
Now: $139.56
$139.75
50-Day Range
$127.70
MA: $133.35
$139.59
52-Week Range
$121.00
Now: $139.56
$148.59
Volume5.47 million shs
Average Volume7.17 million shs
Market Capitalization$367.30 billion
P/E Ratio17.06
Dividend Yield2.73%
Beta0.7
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide. It operates in three segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment offers baby care products under the JOHNSON'S brand; oral care products under the LISTERINE brand; beauty products under the AVEENO, CLEAN & CLEAR, DABAO, JOHNSON'S Adult, LE PETITE MARSEILLAIS, NEUTROGENA, and OGX brands; over-the-counter medicines, including acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; and acid reflux products under the PEPCID brand. Read More…

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryPharmaceuticals
SectorMedical
CUSIP47816010
Phone732-524-0400

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$81.58 billion
Cash Flow$11.07 per share
Book Value$22.28 per share

Profitability

Net Income$15.30 billion

Miscellaneous

Employees135,100
Outstanding Shares2,631,873,000
Market Cap$367.30 billion
Next Earnings Date1/28/2020 (Estimated)
OptionableOptionable

Receive JNJ News and Ratings via Email

Sign-up to receive the latest news and ratings for JNJ and its competitors with MarketBeat's FREE daily newsletter.


Johnson & Johnson (NYSE:JNJ) Frequently Asked Questions

What is Johnson & Johnson's stock symbol?

Johnson & Johnson trades on the New York Stock Exchange (NYSE) under the ticker symbol "JNJ."

How often does Johnson & Johnson pay dividends? What is the dividend yield for Johnson & Johnson?

Johnson & Johnson announced a quarterly dividend on Thursday, October 17th. Stockholders of record on Tuesday, November 26th will be given a dividend of $0.95 per share on Tuesday, December 10th. This represents a $3.80 annualized dividend and a dividend yield of 2.72%. The ex-dividend date of this dividend is Monday, November 25th. View Johnson & Johnson's Dividend History.

How will Johnson & Johnson's stock buyback program work?

Johnson & Johnson announced that its board has approved a stock buyback plan on Monday, December 17th 2018, which authorizes the company to buyback $5,000,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization authorizes the company to purchase up to 1.5% of its shares through open market purchases. Shares buyback plans are generally an indication that the company's leadership believes its stock is undervalued.

How were Johnson & Johnson's earnings last quarter?

Johnson & Johnson (NYSE:JNJ) issued its earnings results on Tuesday, October, 15th. The company reported $2.12 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $2.00 by $0.12. The business had revenue of $20.73 billion for the quarter, compared to the consensus estimate of $20.14 billion. Johnson & Johnson had a return on equity of 39.81% and a net margin of 21.09%. The business's revenue was up 1.9% on a year-over-year basis. During the same period in the previous year, the business posted $2.05 earnings per share. View Johnson & Johnson's Earnings History.

When is Johnson & Johnson's next earnings date?

Johnson & Johnson is scheduled to release their next quarterly earnings announcement on Tuesday, January 28th 2020. View Earnings Estimates for Johnson & Johnson.

What guidance has Johnson & Johnson issued on next quarter's earnings?

Johnson & Johnson updated its FY19 earnings guidance on Tuesday, October, 15th. The company provided EPS guidance of $8.62-8.67 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $8.61. The company issued revenue guidance of $81.8-82.3 billion, compared to the consensus revenue estimate of $81.59 billion.

What price target have analysts set for JNJ?

13 Wall Street analysts have issued 12-month price objectives for Johnson & Johnson's stock. Their forecasts range from $140.00 to $169.00. On average, they anticipate Johnson & Johnson's share price to reach $153.27 in the next year. This suggests a possible upside of 9.8% from the stock's current price. View Analyst Price Targets for Johnson & Johnson.

What is the consensus analysts' recommendation for Johnson & Johnson?

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Johnson & Johnson in the last year. There are currently 5 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Johnson & Johnson.

Has Johnson & Johnson been receiving favorable news coverage?

Media stories about JNJ stock have trended somewhat positive this week, InfoTrie Sentiment reports. The research firm identifies negative and positive press coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Johnson & Johnson earned a news impact score of 1.7 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View News Stories for Johnson & Johnson.

Who are some of Johnson & Johnson's key competitors?

What other stocks do shareholders of Johnson & Johnson own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Johnson & Johnson investors own include AT&T (T), Verizon Communications (VZ), Walt Disney (DIS), Cisco Systems (CSCO), Pfizer (PFE), Procter & Gamble (PG), Intel (INTC), JPMorgan Chase & Co. (JPM), Exxon Mobil (XOM) and Boeing (BA).

Who are Johnson & Johnson's key executives?

Johnson & Johnson's management team includes the folowing people:
  • Mr. Alex Gorsky, Chairman & CEO (Age 59)
  • Mr. Joseph J. Wolk CPA, Exec. VP & CFO (Age 52)
  • Dr. Paulus A. Stoffels, Chief Scientific Officer (Age 57)
  • Mr. Michael H. Ullmann, Exec. VP & Gen. Counsel (Age 60)
  • Mr. Joaquin Duato, Vice Chairman of Exec. Committee (Age 56)

Who are Johnson & Johnson's major shareholders?

Johnson & Johnson's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include State Street Corp (5.76%), Massachusetts Financial Services Co. MA (1.01%), Fisher Asset Management LLC (0.46%), Sumitomo Mitsui Trust Holdings Inc. (0.41%), California Public Employees Retirement System (0.39%) and Parametric Portfolio Associates LLC (0.37%). Company insiders that own Johnson & Johnson stock include Alex Gorsky, Charles Prince, Joaquin Duato, Marillyn A Hewson, Michael E Sneed, Paulus Stoffels, Peter Fasolo and Ronald A Kapusta. View Institutional Ownership Trends for Johnson & Johnson.

Which institutional investors are selling Johnson & Johnson stock?

JNJ stock was sold by a variety of institutional investors in the last quarter, including Phocas Financial Corp., Boston Partners, State Street Corp, Close Asset Management Ltd, State of New Jersey Common Pension Fund D, Parametric Portfolio Associates LLC, Eagle Asset Management Inc. and Artemis Investment Management LLP. View Insider Buying and Selling for Johnson & Johnson.

Which institutional investors are buying Johnson & Johnson stock?

JNJ stock was acquired by a variety of institutional investors in the last quarter, including California Public Employees Retirement System, Assenagon Asset Management S.A., Commerzbank Aktiengesellschaft FI, Voloridge Investment Management LLC, Ilmarinen Mutual Pension Insurance Co, Fisher Asset Management LLC, First Trust Advisors LP and Great West Life Assurance Co. Can. Company insiders that have bought Johnson & Johnson stock in the last two years include Charles Prince and Marillyn A Hewson. View Insider Buying and Selling for Johnson & Johnson.

How do I buy shares of Johnson & Johnson?

Shares of JNJ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Johnson & Johnson's stock price today?

One share of JNJ stock can currently be purchased for approximately $139.56.

How big of a company is Johnson & Johnson?

Johnson & Johnson has a market capitalization of $367.30 billion and generates $81.58 billion in revenue each year. The company earns $15.30 billion in net income (profit) each year or $8.18 on an earnings per share basis. Johnson & Johnson employs 135,100 workers across the globe.View Additional Information About Johnson & Johnson.

What is Johnson & Johnson's official website?

The official website for Johnson & Johnson is http://www.jnj.com/.

How can I contact Johnson & Johnson?

Johnson & Johnson's mailing address is ONE JOHNSON & JOHNSON PLZ, NEW BRUNSWICK NJ, 08933. The company can be reached via phone at 732-524-0400.


MarketBeat Community Rating for Johnson & Johnson (NYSE JNJ)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  865 (Vote Outperform)
Underperform Votes:  942 (Vote Underperform)
Total Votes:  1,807
MarketBeat's community ratings are surveys of what our community members think about Johnson & Johnson and other stocks. Vote "Outperform" if you believe JNJ will outperform the S&P 500 over the long term. Vote "Underperform" if you believe JNJ will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/5/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel